150 related articles for article (PubMed ID: 19844736)
1. Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy.
Yoon JS; Choi SH; Lee JH; Lee SJ; Lee SY
Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):271-6. PubMed ID: 19844736
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy.
Huang D; Xu N; Song Y; Wang P; Yang H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):619-25. PubMed ID: 22124787
[TBL] [Abstract][Full Text] [Related]
3. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
[TBL] [Abstract][Full Text] [Related]
4. Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids.
Xu N; Cui Y; Fu D; Sun F
J Endocrinol Invest; 2020 Jul; 43(7):901-910. PubMed ID: 31927748
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
6. Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy.
Huang D; Luo Q; Yang H; Mao Y
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4935-43. PubMed ID: 24994866
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis.
Lee HK; Lee KS; Kim HC; Lee SH; Kim EK
Am J Ophthalmol; 2005 Jun; 139(6):965-71. PubMed ID: 15953424
[TBL] [Abstract][Full Text] [Related]
8. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
9. Dry eye syndrome in thyroid-associated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies.
Eckstein AK; Finkenrath A; Heiligenhaus A; Renzing-Köhler K; Esser J; Krüger C; Quadbeck B; Steuhl KP; Gieseler RK
Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):291-7. PubMed ID: 15115450
[TBL] [Abstract][Full Text] [Related]
10. NGF and iNOS Changes in Tears from Video Display Terminal Workers.
Cortes M; Esposito G; Sacco R; Gillet VB; Ianni A; Micera A
Curr Eye Res; 2018 Sep; 43(9):1119-1125. PubMed ID: 29741396
[TBL] [Abstract][Full Text] [Related]
11. Tear film osmolarity in patients with thyroid ophthalmopathy.
Iskeleli G; Karakoc Y; Abdula A
Jpn J Ophthalmol; 2008; 52(4):323-326. PubMed ID: 18773272
[TBL] [Abstract][Full Text] [Related]
12. Observation of Corneal Langerhans Cells by In Vivo Confocal Microscopy in Thyroid-Associated Ophthalmopathy.
Wu LQ; Cheng JW; Cai JP; Le QH; Ma XY; Gao LD; Wei RL
Curr Eye Res; 2016 Jul; 41(7):927-32. PubMed ID: 26735162
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
14. Alterations of tear neuromediators in dry eye disease.
Lambiase A; Micera A; Sacchetti M; Cortes M; Mantelli F; Bonini S
Arch Ophthalmol; 2011 Aug; 129(8):981-6. PubMed ID: 21825181
[TBL] [Abstract][Full Text] [Related]
15. Eye muscle antibodies and subtype of thyroid-associated ophthalmopathy.
Kaspar M; Archibald C; De BA; Li AW; Yamada M; Chang CH; Kahaly G; Wall JR
Thyroid; 2002 Mar; 12(3):187-91. PubMed ID: 11952037
[TBL] [Abstract][Full Text] [Related]
16. Thyroid-associated orbitopathy and tears: A proteomics study.
Kishazi E; Dor M; Eperon S; Oberic A; Hamedani M; Turck N
J Proteomics; 2018 Jan; 170():110-116. PubMed ID: 28887209
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathy.
Kubota S; Gunji K; Stolarski C; Kennerdell JS; Wall J
Thyroid; 1998 Feb; 8(2):175-9. PubMed ID: 9510127
[TBL] [Abstract][Full Text] [Related]
18. [Tear film analysis and its relation with palpebral fissure height and exophthalmos in Graves' ophthalmopathy].
Brasil MV; Brasil OF; Vieira RP; Vaisman M; Amaral Filho OM
Arq Bras Oftalmol; 2005; 68(5):615-8. PubMed ID: 16322856
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy.
Zhou X; Wei R; Wang R
PeerJ; 2022; 10():e13701. PubMed ID: 35846879
[TBL] [Abstract][Full Text] [Related]
20. [Expressions of lysozyme C and lactoferrin in tears of thyroid-associated ophthalmopathy patients].
Jiang L; Mou P; Wei R
Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(10):749-52. PubMed ID: 26080846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
